Literature DB >> 10425271

Increased expression of CD40 on thymocytes and peripheral T cells in autoimmunity: a mechanism for acquiring changes in the peripheral T cell receptor repertoire.

D H Wagner1, E Newell, R J Sanderson, J H Freed, M K Newell.   

Abstract

CD40, a cell surface molecule found on B lymphocytes and other antigen presenting cells, can, when engaged by CD40 ligand (CD40L), induce gene rearrangements and isotype switching. We report here that CD40 is also expressed on thymocytes and on up to 50% of peripheral T cells from autoimmune prone strains of mice. In normal animals, CD40 is present on a small population of T cells and thymocytes. CD40 is expressed on most T cell hybridomas. We demonstrate that CD40 engagement on peripheral T cells, T cell hybridomas and thymocytes results in altered TCRValpha expression. That induced expression of different Valpha's results from the activity of the recombinase gene is implied by the observation that CD40 does not induce TCR changes in RAG knock-out mice. Total cell numbers remained unchanged between anti-CD40 treated and untreated populations of thymocytes or T cells indicating that treatment does not induce cell proliferation or cell death. The data presented here suggest a mechanism by which self reactive T cells accumulate peripherally and independently of selective processes of the thymus.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10425271     DOI: 10.3892/ijmm.4.3.231

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  14 in total

1.  CD40 glycoforms and TNF-receptors 1 and 2 in the formation of CD40 receptor(s) in autoimmunity.

Authors:  Gisela M Vaitaitis; David H Wagner
Journal:  Mol Immunol       Date:  2010-06-19       Impact factor: 4.407

2.  The co-evolution of our understanding of CD40 and inflammation.

Authors:  D H Wagner
Journal:  Diabetologia       Date:  2009-04-10       Impact factor: 10.122

Review 3.  Of the multiple mechanisms leading to type 1 diabetes, T cell receptor revision may play a prominent role (is type 1 diabetes more than a single disease?).

Authors:  D H Wagner
Journal:  Clin Exp Immunol       Date:  2016-07-25       Impact factor: 4.330

Review 4.  CD4 T cells and their antigens in the pathogenesis of autoimmune diabetes.

Authors:  Kathryn Haskins; Anne Cooke
Journal:  Curr Opin Immunol       Date:  2011-09-12       Impact factor: 7.486

5.  Expression of CD40 identifies a unique pathogenic T cell population in type 1 diabetes.

Authors:  David H Wagner; Gisela Vaitaitis; Richard Sanderson; Michelle Poulin; Cathleen Dobbs; Kathryn Haskins
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

Review 6.  Targeting Type 1 Diabetes: Selective Approaches for New Therapies.

Authors:  Daniel F Sheehy; Sean P Quinnell; Arturo J Vegas
Journal:  Biochemistry       Date:  2019-01-17       Impact factor: 3.162

7.  CD154 is a negative regulator of autoaggressive CD8+ T cells in type 1 diabetes.

Authors:  Catrin M McGregor; Stephen P Schoenberger; E Allison Green
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-10       Impact factor: 11.205

8.  A CD40-targeted peptide controls and reverses type 1 diabetes in NOD mice.

Authors:  Gisela M Vaitaitis; Michael H Olmstead; Dan M Waid; Jessica R Carter; David H Wagner
Journal:  Diabetologia       Date:  2014-08-08       Impact factor: 10.122

9.  Disruption of the homeostatic balance between autoaggressive (CD4+CD40+) and regulatory (CD4+CD25+FoxP3+) T cells promotes diabetes.

Authors:  Dan M Waid; Gisela M Vaitaitis; Nathan D Pennock; David H Wagner
Journal:  J Leukoc Biol       Date:  2008-05-09       Impact factor: 4.962

10.  CD40 interacts directly with RAG1 and RAG2 in autoaggressive T cells and Fas prevents CD40-induced RAG expression.

Authors:  Gisela M Vaitaitis; David H Wagner
Journal:  Cell Mol Immunol       Date:  2013-09-16       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.